Advertisement
rahul kakkad

Rahul Kakkad

Innovation in the sector has a high lead time and is also heavily dependent on capital intensive R&D.

Can Budget 2022 prove to be an immunity booster for the lifesciences sector?

by Rahul Kakkad |Jan 22, 2022

Amid a rapidly changing demography and government initiatives, some gaps continue to remain in the ability of the sector to contribute significantly to the GDP of the country.